Enantioselective Synthesis of a PKC Inhibitor via Catalytic C−H Bond Activation
摘要:
The syntheses of two biologically active molecules possessing dihydropyrroloindole cores (1 and 2) were completed using rhodium-catalyzed imine-directed CA bond functionalization, with the second of these molecules containing a stereocenter that can be set with 90% ee during cyclization using chiral nonracemic phosphoramidite ligands. Catalytic decarbonylation and direct indole/maleimide coupling provide efficient access to 2.
[EN] INDOLE-3-METHANAMINES USEFUL AS ANTI-DIABETIC, ANTI-OBESITY AND ANTI-ATHEROSCLEROTIC AGENTS
申请人:THE UPJOHN COMPANY
公开号:WO1992007829A1
公开(公告)日:1992-05-14
(EN) The present invention provides novel compounds which are useful in the treatment of NIDDM, obesity, hypertension or atherosclerosis. This invention encompasses a compound of formula (I), wherein R1-R6 represent a variety of substituents, and a method of treatment of the above conditions.(FR) Nouveaux composés utilisés dans le traitement du diabète sucré indépendant de l'insuline (NIDDM), de l'obésité, de l'hypertension ou de l'athérosclérose. L'invention comprend un composé de formule (I), dans laquelle R1-R6 représentent toute une variété de substituants, ainsi qu'un procédé de traitement des conditions pathologiques susmentionnées.